Patent State Prize for Tremitas tremor measurement device

alt text
Engineering & IT

CUAS graduate and Tremitas founder Tibor Zajki-Zechmeister was awarded for the best patent

The medical technology company Tremitas was honored with the highest award for inventive talent and innovative product development by Federal Minister Leonore Gewessler and the Austrian Patent Office on November 9, 2020. The State Prize Patent in the category "Humanity" was awarded for the development of the tremor measuring device, Tremipen.

Already during his bachelor studies in the branch "Medical Engineering" Tibor Zajki-Zechmeister pushed his research for the innovative product development of the Tremipen with great passion. The product, which was awarded the Patent State Prize, is similar to a ballpoint pen with a digital display, which measures the tremor of the hands within seconds in people with Parkinson's disease and other tremor disorders. The sensor contained in the Tremipen is able to measure and immediately evaluate the tremor: Within seconds, the measured value appears on the display.

According to estimates, approximately 20,000 people in Austria are affected by the neurological disease Parkinson's, worldwide one in ten people is even affected by tremor. "By means of objective data on tremor, also known as tremor, it is now possible to support the diagnosis and therapy of millions of people with the help of tremiping and to accompany them in their everyday life", explains Tibor Zajki-Zechmeister, CEO of Tremitas GmbH proudly.

In 2015, Tibor Zajki-Zechmeister founded Tremitas GmbH, a high-tech medical technology company with headquarters in Klagenfurt that now operates internationally. The company's success story began with the delivery of the Tremipen to clinics and physicians. The company also received support from the Gründergarage of the Carinthia University of Applied Sciences. From 2018 to 2020, the Tremitas managing director successfully completed the master's degree program in Health Care IT, a decision to supplement knowledge acquired in practice with academic and theoretical foundations. Above all, the subject areas such as human medicine, advanced medical devices or machine learning were of great importance to the prize winner in order to be able to incorporate know-how from them into his product development. "It is possible to run a medical technology company and at the same time complete a demanding full-time course of study," says FH graduate, Tibor Zajki-Zechmeister, and is particularly pleased about the State Prize, which recognizes the company's innovative spirit. "The patent now protects the Tremipen against copying and also the software algorithm for tremor analysis, which has been developed over three years," Zajki-Zechmeister continues and is confident that the Tremipen will become a global measurement standard for tremor disorders.

We congratulate and wish you good luck!